Royalty Pharma to release third quarter 2024 financial results on November 6.

From GlobeNewswire: 2024-10-16 16:15:00

Royalty Pharma plc (Nasdaq: RPRX) will release its third quarter 2024 financial results on November 6, 2024, before the U.S. markets open. A conference call and webcast will follow at 8:30 a.m. Eastern Time. Royalty Pharma is the largest buyer of biopharmaceutical royalties and collaborates with various industry players.

Founded in 1996, Royalty Pharma partners with academic institutions and pharmaceutical companies, holding royalties on 35 commercial products and 16 development-stage candidates. The company funds innovation in the biopharmaceutical industry by providing capital for late-stage clinical trials and new product launches in exchange for future royalties. Investors can find detailed conference call information on Royalty Pharma’s website.

For more information on Royalty Pharma and their portfolio, visit their website. Investors and press can contact Royalty Pharma Investor Relations and Communications at +1 (212) 883-6637 or email [email protected]. The conference call and webcast replay will be available on the company’s site for at least 30 days after the event.



Read more at GlobeNewswire:: Royalty Pharma to Announce Third Quarter 2024 Financial